Literature DB >> 6129854

[Effect of memantine on central neurotransmitter systems. Review of the results].

J Maj.   

Abstract

In the present review the effects of 1,3-dimethyl-5-amino-adamantane (DMAA, D-145, Memantine, Memantine) on various neurotransmitter systems were presented. The most marked effect of DMAA seems to be the stimulation of dopaminergic neurons as reflected by the respective behavioural changes and biochemical effects. The stimulatory action on noradrenaline and serotonin neurons (at least partially indirectly through the activation of dopamine system) as well as on GABA neurons is apparent. No direct effects on Dopamine, alpha 1, alpha 2, Serotonin, GABA, benzodiazepine and opiate receptors were found. DMAA can be assigned to a new class of compounds which act mainly as dopaminomimetics, but its mode of action is apparently different from those of amphetamine or apomorphine. It differs quantitatively and qualitatively from amantadine, another derivative of adamantane.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6129854

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats.

Authors:  W Löscher; D Hönack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

3.  Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane. Pharmacological studies in rodents and baboon, Papio papio.

Authors:  B S Meldrum; L Turski; M Schwarz; S J Czuczwar; K H Sontag
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-01       Impact factor: 3.000

4.  Modulation of NMDA effects on agonist-stimulated phosphoinositide turnover by memantine in neonatal rat cerebral cortex.

Authors:  R Mistry; R Wilke; R A Challiss
Journal:  Br J Pharmacol       Date:  1995-02       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.